Introduction: Decision aids for prostate cancer screening can increase knowledge and shared decision making, but remain underused due to cost and time constraints that disrupt clinic flow. We examined the impact of a simple prostate specific antigen screening decision aid distribution strategy on clinic flow as well as shared decision making in a diverse, urban primary care clinic.
The controversial USPSTF recommendation against routine PSA screening has decreased the rates of PSA screening and early diagnosis of prostate cancer since 2012, 1, 2 with unclear future consequences as rates of men presenting with advanced disease may be on the rise. 3 In addition, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, 4 which was weighted heavily in the USPSTF decision to recommend against PSA screening, was found to have significant methodological concerns including an approximately 90% contamination rate (men receiving PSA tests that were not intended to) in the control arm, 5 thereby calling into question the validity of the conclusion of the study that there was no advantage to PSA screening. 6 Furthermore, there is little to no evidence to guide recommendations for high risk men such as those with a family history of prostate cancer and African American men, 2 groups who might stand to benefit more from screening than men of average risk. Therefore, despite the USPSTF recommendation many men will still likely benefit from shared decision making regarding prostate cancer screening as endorsed by the AUA in their guideline for the early detection of prostate cancer. 7 In addition, SDM was recently highlighted in an AUA white paper as an important component of high quality health care delivery, and that it may soon be tied to reimbursement models. 8 Therefore, effectively implementing SDM around PSA screening remains extremely important. Barriers to SDM include resources, patient preferences and applicability of SDM for particular clinical situations. 9 Decision aids may overcome some of these barriers, and have been shown to enhance SDM and effect behavior change. However, many require significant costs and time to implement, preventing their use by most practices. 10e16 Physicians may be more willing to engage in SDM if it can be done in a time and cost conscious manner potentially benefitting many patients. Therefore, we evaluated the impact of a simple delivery method for a PSA screening decision aid on physicians, clinic staff and clinic work flow, as well as on shared decision making.
Materials and Methods
This study was approved by the University of Minnesota institutional review board and registered on ClinicalTrials.gov. Eligible men were 50 to 75 years old, scheduled to see a physician and English speaking. Patients with prostate cancer, a history of prostate biopsy or PSA testing within the last 12 months, voiding problems as the reason for the visit, or their scheduled appointment the same day they were being seen, presumably for urgent problems for whom discussion of PSA screening would not be appropriate, were excluded from study. Physician participants were family medicine residents and faculty working in a diverse urban clinic. Recruitment for the study occurred over approximately 6 months involving parts of 44 clinics. Participants were identified from a list of scheduled patients for the day. Front desk staff gave potential participants information about the study. A research assistant confirmed eligibility and provided the participant with the DA to read while waiting for the physician. After the visit patients and their physicians completed written surveys and patients were then given a $20 gift card.
The DA used in this study was a slightly modified version of the previously validated PROCASE DA, which is written at a 6th grade level (supplementary Appendix 1, http://urologypracticejournal.com/).
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Modifications reflected information from the PLCO Cancer Screening Trial and the European Randomized Study of Screening for Prostate Cancer. 4, 17 The patient participant survey was a 44-item tool, including the Knowledge of Prostate Cancer tool, with the number of correct answers summed to create a scale score (0 to 10), 18 and the Decisional Conflict Scale, with a modified version that used only positive statements to allow for consistent scoring. 19 The total score was calculated as described by O'Connor to produce a scale ranging from 5 (no conflict) to 80 (extremely high decisional conflict).
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The Satisfaction With Decision Scale items were summed to produce a scale score ranging from 0 (strongly dissatisfied) to 30 (extremely satisfied), whether a PSA screening discussion occurred, preference for involvement in decision making and time spent viewing the DA. 20 The provider survey consisted of 7 items assessing whether a discussion of screening occurred, quality of the discussion, whether a decision was made and time spent in SDM. Summary descriptive statistics were used for subject characteristics, survey items, scale scores, time viewing the DA and provider survey results. Generalized linear models examined the influence of covariates on levels of decisional conflict and satisfaction.
Four focus groups were conducted at the midway point (phase I) of the study to identify changes to improve the SDM intervention, and another 5 focus groups were conducted at the end of the study to assess the efficacy of the process (focus group interview guide available in supplementary Appendix 2, http://urologypracticejournal.com/). The clinic staff and physician FGs were held separately. Each FG included 8 to 15 participants. All focus groups were conducted by the second coauthor (JMB, who has more than 10 years of experience conducting focus groups) with a research assistant. The taperecorded FGs were transcribed verbatim and a grounded hermeneutic approach was used. This type of approach focuses on people's perceptions of the world in which they live and their meanings. This type of analysis includes describing, organizing, connecting, corroborating and representing the lived experience of the participant in themes. 21, 22 The qualitative data were analyzed using NVivo 10 qualitative analysis software (QSR International Pty. Ltd, Melbourne, Australia). Table 3 shows that the physician reported mean time discussing screening was only 5.2 minutes.
Results
While not the main focus of our study, we evaluated whether there were differences between AA and Caucasian men in the use of the DA and SDM given the disproportionate burden from prostate cancer borne by AA men. We found that AA men were more likely to have a discussion about screening (60% vs 29%, p¼0.04) than nonAA men (data not shown).
Themes identified by clinic staff and physicians from the phase I FGs included time constraints, training, communication and lack of knowledge about the DA (see Participants with missing data were excluded from each analysis. Percentages may not add up to 100 due to rounding. *Number of questions answered correctly out of 10.
y "Screening decision occurred" indicates that a decision regarding screening was made during the visit but does not indicate that a PSA test was or was not actually obtained. Phase II FG results indicated that overall, clinic staff and physicians were satisfied with the changes made from phase I. Front desk staff reported they felt "more involved" with the distribution of the DA, making them more "likely to talk with potential participants" about the study. Physicians reported that the SDM process using the DA "felt comfortable," making them more likely to engage in SDM, and that the SDM process "seemed to work" with their patients.
Discussion
Our results suggest that distribution of DAs to patients waiting for their clinician empowers men to start SDM discussions regarding PSA screening without significant increases in time or cost. Patients and physicians reported acceptance of the DA while clinic staff and providers reported the intervention was feasible to implement. This approach capitalizes on downtime in the physician's office, avoids a separate visit and increases encounter time by only 5 to 10 minutes. It overcomes barriers of time and cost seen in other studies using sophisticated strategies such as mailing DAs ahead of time or using web based tools. 12, 23, 24 The application of these other approaches may be limited in patient populations that move frequently, making mailings unreliable. Web based interventions may be less effective for those who do not have easy Internet access or lack computer literacy. Furthermore, our approach allows for SDM discussions to occur in the same setting, in contrast to a scenario described by Tran et al where a simple printed DA was distributed but only after the physician visit. 16 Another aspect of our approach was to provide training on how to conduct SDM. Resident participants had 2, 50-minute training sessions during the course of the study. We chose to focus on the "ask-tell-ask" approach to SDM. 25 Training in this simplified approach to SDM may also have contributed to the effectiveness of our approach in 2 ways. The training may have increased physician confidence in engaging patients in SDM, and the use of this simplified approach helped keep the required time to achieve SDM to a minimum, thereby increasing the likelihood of acceptance of the approach. Furthermore, the majority of physicians reported that the DA made the PSA screening discussion easier. Therefore, our approach seems to accomplish the goals of facilitating SDM without significantly increasing the encounter time, even when a patient is coming to clinic for a different reason. It should be noted that these results were accomplished in a population consisting of nearly 70% AA men, a group at high risk for prostate cancer for which no evidence-based guidance exists. Thus, they are likely to benefit from SDM on this topic. It is interesting to note that AA men chose to discuss screening at much higher rates than Caucasian men. While we do not have the data to determine the explanation, there may be bias in the counseling of AA men compared to the counseling of Caucasian men by physicians. Alternatively, it may simply be that after informing AA men that they are at increased risk for diagnosis of and death from prostate cancer compared to Caucasian men, they chose to discuss screening at higher rates. Further research may help explain this difference. In addition, while these results were achieved in a resident run primary care clinic, the approach may be even more successful when implemented by physicians more experienced navigating difficult clinical decisions or in urology clinics where patients may be even more receptive to thinking about urology related topics, even if PSA testing is not the primary reason for their visit.
A particular strength of our study was in using a mixed methods approach, which few studies to date have done. This led to one of the most interesting and unanticipated findings of our study, which was the desire for involvement on the part of the front desk and nursing staff. These important members of the care team have a dramatic impact on the work flow in the clinic but they are often overlooked in terms of their role in interacting with patients. However, it was clear from our focus groups that these individuals felt strongly that they wanted to be empowered with a minimum amount of information to be able to answer basic questions about the DA. Furthermore, exposing patients to information about the DA at multiple points during the visit likely reinforced the importance of the DA, and may have facilitated its use.
While it is not the role of the front desk or nursing assistants to provide counseling to patients regarding health care decisions per se, including these individuals in the process by providing them with simple talking points explaining the purpose of the DA greatly facilitated their willingness to participate in and their satisfaction with the process, minimizing any negative perception of the impact of the DA on the work flow in the clinic, a major barrier to the use of DAs. Thus, successful implementation of SDM strategies may require a broader clinic-wide strategy beyond the physician/patient focus.
Limitations of our study include length of surveys, sample size and lack of control groups in this 1-site pilot study. These limitations preclude definitive conclusions about the effectiveness of this approach.
Conclusion
Our simple approach of presenting a PSA screening DA to patients while they await their physician appears to be feasible without significantly increasing costs or time. Maximization of the approach may be realized with training physicians in the use of SDM and a broad clinic-wide approach involving all members of the clinic team in the process. This approach may be broadly applicable for encouraging SDM regarding PSA screening and many other difficult medical decisions.
Editorial Commentary
AUA guidelines call for us to undertake a shared decision making dialogue with each eligible patient regarding the advantages and drawbacks of PSA screening. But how do we realistically implement this requirement in the high volume, expedited turnover environment of contemporary clinical practice?
In the family practice clinic described here, providing each patient with a standardized decision aid handout proved a welcome intervention. However, while 93% of the patients found that the DA rendered them more likely to discuss PSA screening, only half went on to do so during that visit. Only about 1 of 3 made a final decision then, one way or the other.
In terms of minimizing the impact on patient flow in the clinic, implementation of this DA initiative was deemed successful. But in a larger sense its success remains undetermined. Most of those men who declined PSA screening were satisfied with their decision. But how satisfied will they feel, years ahead, when they are brought to the emergency room with a pathological fracture secondary to metastatic prostate cancer?
Shared decision making should never deteriorate to "punt the problem to your patient." Not all patients want us to make a decision for them (although some do), but almost all would like to make their decision along with us. "MD" should always mean more than Maître D'. We owe our patients more than an open-ended menu of enigmatic options. Always be ready when your patient asks, "Doctor, I trust in your advice. What would you recommend I do?" 
Reply by Authors
We appreciate the viewpoint of Dr. Watson, but would like to offer another perspective. We find the fact that any men, let alone half, went on to have a discussion about a topic that they had not planned on discussing, which likely had not crossed their minds recently until receiving the DA, impressive for an intervention requiring minimal time or financial investment. Furthermore, the fact that the clinic staff did not find the intervention prohibitively disruptive increases the likelihood that it can be a sustained approach and applicable to a variety of difficult clinical decisions. Whether patients choose to undergo screening or not was not the focus of our study.
Rather it was to determine if the intervention could stimulate a shared decision making discussion where there otherwise would not be one, and do it in a way that did not completely disrupt the clinic flow. As the information regarding the benefits of PSA screening continues to be more compelling, the data will speak for themselves, and many more men may choose screening after an informed discussion with their physician. It is our job to provide the data and the opportunities to have those discussions.
